Maryam Majidinia

6.7k total citations · 2 hit papers
118 papers, 4.9k citations indexed

About

Maryam Majidinia is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Maryam Majidinia has authored 118 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 34 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Maryam Majidinia's work include MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (13 papers) and Genomics, phytochemicals, and oxidative stress (11 papers). Maryam Majidinia is often cited by papers focused on MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (13 papers) and Genomics, phytochemicals, and oxidative stress (11 papers). Maryam Majidinia collaborates with scholars based in Iran, Canada and United States. Maryam Majidinia's co-authors include Bahman Yousefi, Alireza Sadeghpour, Ainaz Mihanfar, Ansar Karimian, Mohammad Mirza‐Aghazadeh‐Attari, Saber Ghazizadeh Darband, Mojtaba Kaviani, Shirin Sadighparvar, Hadi Parsian and Rüssel J. Reiter and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and British Journal of Pharmacology.

In The Last Decade

Maryam Majidinia

115 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The roles of signaling pathways in bone repair and regeneration

2017 392 citations Maryam Majidinia, Bahman Yousefi et al. Journal of Cellular Physiology profile →
Probing the biological activity of isatin derivatives against human lung cancer A549 cells: Cytotoxicity, CT-DNA/BSA binding, DFT/TD-DFT, topology, ADME-Tox, docking and dynamic simulations

2025 32 citations Somayyeh Ghareghomi, Maryam Majidinia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maryam Majidinia Iran	43	2.6k	1.1k	588	411	393	118	4.9k
Yunjin Jung South Korea	37	2.4k 0.9×	1.2k 1.1×	534 0.9×	425 1.0×	347 0.9×	144	5.6k
Sang Hun Lee South Korea	37	2.3k 0.9×	760 0.7×	627 1.1×	410 1.0×	349 0.9×	114	4.8k
Ana Maria Oliveira Battastini Brazil	43	1.9k 0.8×	367 0.3×	517 0.9×	371 0.9×	519 1.3×	195	6.0k
Meinhard Wlaschek Germany	43	2.4k 0.9×	531 0.5×	356 0.6×	264 0.6×	882 2.2×	96	7.6k
Siyu Chen China	34	1.7k 0.7×	585 0.5×	227 0.4×	300 0.7×	471 1.2×	235	3.8k
Li Zhang China	33	1.8k 0.7×	659 0.6×	399 0.7×	200 0.5×	265 0.7×	222	3.8k
Adeeb Shehzad South Korea	31	2.1k 0.8×	725 0.7×	298 0.5×	266 0.6×	447 1.1×	84	4.5k
Patrick Netter France	41	1.9k 0.7×	484 0.4×	514 0.9×	510 1.2×	528 1.3×	176	6.0k
Wei‐Chien Huang Taiwan	44	3.2k 1.2×	1.2k 1.1×	1.3k 2.2×	188 0.5×	327 0.8×	123	5.8k
Kun Zhang China	41	3.2k 1.2×	1.9k 1.7×	455 0.8×	199 0.5×	570 1.5×	232	6.3k

Countries citing papers authored by Maryam Majidinia

Since Specialization

Citations

This map shows the geographic impact of Maryam Majidinia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Majidinia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Majidinia more than expected).

Fields of papers citing papers by Maryam Majidinia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Majidinia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Majidinia. The network helps show where Maryam Majidinia may publish in the future.

Co-authorship network of co-authors of Maryam Majidinia

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Majidinia. A scholar is included among the top collaborators of Maryam Majidinia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Majidinia. Maryam Majidinia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Majidinia, Maryam, et al.. (2025). The reciprocal effects of autophagy and the Warburg effect in pancreatic ductal adenocarcinoma: an in vitro study. Medical Oncology. 42(4). 86–86. 2 indexed citations

Majidinia, Maryam, et al.. (2025). Critical Contribution of Various Signaling Pathways in the Development of Drug Resistance in Colorectal Cancer: An Update. IUBMB Life. 77(11). e70074–e70074. 1 indexed citations

Maghsoudi, Hossein, et al.. (2024). Exploring the therapeutic potential of quercetin in cancer treatment: Targeting long non-coding RNAs. Pathology - Research and Practice. 260. 155374–155374. 11 indexed citations

Ghareghomi, Somayyeh, et al.. (2024). Exploring MIL-68(Al) nanocarrier for melatonin delivery: probing pro-oxidant effects in cancer cells and achieving sustained drug release. Journal of Industrial and Engineering Chemistry. 142. 206–216. 4 indexed citations

Nasehi, Mohammad, et al.. (2024). Polyphenols Modulate the miRNAs Expression that Involved in Glioblastoma. Mini-Reviews in Medicinal Chemistry. 24(21). 1953–1969. 1 indexed citations

Yousefi, Bahman, et al.. (2024). lncRNAs: New players of cancer drug resistance via targeting ABC transporters. IUBMB Life. 76(11). 883–921. 19 indexed citations

Yousefi, Bahman, et al.. (2024). Reversal effect of fenofibrate on P-glycoprotein-mediated multidrug resistance through PPARγ-dependent upregulation of PTEN expression in SW-480 colorectal cancer cells. 35(6). 467–478. 2 indexed citations

Mihanfar, Ainaz, et al.. (2024). Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response. Molecular Biology Reports. 51(1). 474–474. 4 indexed citations

Rahmati‐Yamchi, Mohammad, et al.. (2024). Emerging Insights into the PI3K/AKT/mTOR Signaling Pathway and Non-Coding RNA-mediated Drug Resistance in Glioblastoma. Current Molecular Medicine. 25(6). 710–722. 2 indexed citations

10.

Hallaj, Tooba, et al.. (2024). WS2 QDs based dual fluorometric and paper based colorimetric sensor for Pb2+ assay in water and food samples. Journal of Food Composition and Analysis. 139. 107097–107097.

11.

Mihanfar, Ainaz, Niloufar Targhazeh, Shirin Sadighparvar, et al.. (2021). Doxorubicin loaded magnetism nanoparticles based on cyclodextrin dendritic-graphene oxide inhibited MCF-7 cell proliferation. BioMolecular Concepts. 12(1). 8–15. 23 indexed citations

12.

Sadighparvar, Shirin, Saber Ghazizadeh Darband, Firouz Ghaderi Pakdel, Ainaz Mihanfar, & Maryam Majidinia. (2021). Parasympathetic, but not sympathetic denervation, suppressed colorectal cancer progression. European Journal of Pharmacology. 913. 174626–174626. 17 indexed citations

13.

Süntar, İpek, Antonio García‐Ríos, Tarun Belwal, et al.. (2020). Natural products, PGC-1 , and Duchenne muscular dystrophy. Acta Pharmaceutica Sinica B. 10(5). 734–745. 72 indexed citations

14.

Tehrani, Sadra Samavarchi, Tooba Yousefi, Ansar Karimian, et al.. (2020). Critical roles of long noncoding RNAs in breast cancer. Journal of Cellular Physiology. 235(6). 5059–5071. 45 indexed citations

15.

Mirza‐Aghazadeh‐Attari, Mohammad, María J. Recio, Saber Ghazizadeh Darband, et al.. (2020). DNA damage response and breast cancer development: Possible therapeutic applications of ATR, ATM, PARP, BRCA1 inhibition. DNA repair. 98. 103032–103032. 15 indexed citations

16.

Sanches‐Silva, A., Lara Testai, Seyed Fazel Nabavi, et al.. (2020). Therapeutic potential of polyphenols in cardiovascular diseases: Regulation of mTOR signaling pathway. Pharmacological Research. 152. 104626–104626. 109 indexed citations

17.

Jahanban‐Esfahlan, Rana, Khaled Seidi, Maryam Majidinia, et al.. (2019). Toll‐like receptors as novel therapeutic targets for herpes simplex virus infection. Reviews in Medical Virology. 29(4). e2048–e2048. 26 indexed citations

18.

Karimian, Ansar, Hadi Parsian, Maryam Majidinia, et al.. (2019). RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression. Journal of Cellular Physiology. 234(9). 14951–14965. 248 indexed citations

19.

Tehrani, Sadra Samavarchi, Tooba Yousefi, Ansar Karimian, et al.. (2019). MicroRNAs in breast cancer: Roles, functions, and mechanism of actions. Journal of Cellular Physiology. 235(6). 5008–5029. 75 indexed citations

20.

Majidinia, Maryam, et al.. (2016). The roles of non-coding RNAs in Parkinson’s disease. Molecular Biology Reports. 43(11). 1193–1204. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact